GNS-396

N/A

Report date: 2025/05/14 14:16:37

Base Information

Drug NameGNS-396
Drug Alias NameGNS396
ClassificationBiologics
Mechanisms of ActionTyrosine-protein kinase receptor FLT3 inhibitors
TargetsTyrosine-protein kinase receptor FLT3
Therapy Area/IndicationsLeukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGenoscience Pharma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGenoscience Pharma
Active IndicationsN/A
Inactive IndicationsLeukemia, Myeloid, Acute

Other Information

ATC CodeN/A
Related LinksN/A